A detailed history of Saturn V Capital Management LLC transactions in Inozyme Pharma, Inc. stock. As of the latest transaction made, Saturn V Capital Management LLC holds 1,374,582 shares of INZY stock, worth $1.65 Million. This represents 1.49% of its overall portfolio holdings.

Number of Shares
1,374,582
Previous 1,368,810 0.42%
Holding current value
$1.65 Million
Previous $7.16 Billion 46.81%
% of portfolio
1.49%
Previous 2.56%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$2.48 - $5.54 $14,314 - $31,976
5,772 Added 0.42%
1,374,582 $3.81 Billion
Q3 2024

Nov 14, 2024

BUY
$4.31 - $6.0 $984,834 - $1.37 Million
228,500 Added 20.04%
1,368,810 $7.16 Billion
Q2 2024

Aug 14, 2024

BUY
$4.33 - $7.31 $4.94 Million - $8.34 Million
1,140,310 New
1,140,310 $5.09 Billion

Others Institutions Holding INZY

About Inozyme Pharma, Inc.


  • Ticker INZY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,145,700
  • Market Cap $48.2M
  • Description
  • Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, ...
More about INZY
Track This Portfolio

Track Saturn V Capital Management LLC Portfolio

Follow Saturn V Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Saturn V Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Saturn V Capital Management LLC with notifications on news.